Innovative Treatment Access Consulting

Science-backed guidance when conventional treatments are not enough

When conventional treatments reach their limit, most doctors are not expected or equipped to navigate the complex global landscape of emerging clinical research, investigational therapies, and experimental medicine. That is where Biomedical Revolution steps in.

Led by Dr. Omid Fotouhi, PhD, a biomedical scientist and founder of Biomedical Revolution (Sweden), our consulting service provides personalized, science-based guidance to patients and families seeking innovative treatment options that go beyond routine care.

We specialize in identifying early-access therapies, including stem cell, immune cell, gene, and regenerative treatments that are under ethical oversight and scientific validation—but may not yet be approved or available in a patient’s home country. Our approach is rooted in deep research, translational insight, and compassionate coordination.

Why Our Service Matters

Doctors and hospitals provide the best available care according to national and international guidelines. But when all approved options have been exhausted, patients often face a confusing world of unverified claims and vague promises.

We offer:

• Scientific clarity in a complex landscape
• Independent, case-specific research
• A structured bridge between the laboratory, clinical trial, and the individual patient

We work alongside—not instead of—your healthcare team, and help patients understand:

• What advanced treatment options might exist
• Whether those options are safe, ethical, and science-backed
• How these treatments align with the patient’s condition, priorities, and preferences

If the patient decides to pursue a treatment, we also help facilitate the connection with the appropriate clinical team or institution.

What We Provide

At Biomedical Revolution, we offer a structured and professional pathway for patients who are exploring advanced treatment possibilities when routine care is no longer effective. Our services are divided into three complementary components:

1. Personalized Scientific Research & Treatment Mapping

We conduct deep, case-specific analysis to identify potential advanced therapies or clinical programs that are aligned with the patient’s medical condition and history. This includes:

• Reviewing the clinical, diagnostic, and molecular profile of the patient
• Investigating current science-backed treatment innovations under ethical development and regulation
• Identifying early-access programs, clinical trials, or international centers with relevant protocols
• Evaluating safety, scientific rationale, and clinical maturity of each option

Our expertise bridges the gap between laboratory breakthroughs and real-world application—helping patients access credible opportunities beyond the limits of standard care.

2. Clinical Coordination & Access Support

Once scientifically appropriate options are identified, we support the logistical steps toward access, which may include:

• Introducing the patient’s case to relevant clinical teams, trial coordinators, or hospital liaisons
• Facilitating medical document exchange and clinical summaries
• Providing supporting materials to assist the patient’s treating doctor in evaluating the option
• Monitoring communication to ensure timely and ethical responses from destination clinics

We help reduce the friction between discovery and access—while ensuring that communication remains professional, medically sound, and respectful of local and international regulations.

3. Patient Consultation & Decision Guidance

Scientific insight must be matched with clear, personalized guidance, especially when patients are navigating life-changing decisions. We support individuals and families through:

• Explaining available treatment pathways and clinical rationale in a clear, compassionate way
• Comparing pros and cons across multiple destinations and options
• Assessing institutional reputation, transparency, and ethical standing of destination centers
• Helping prioritize options based on expected outcomes, budget, travel feasibility, and patient preferences
• Offering post-report Q&A and clarification sessions as needed

Patients do not just need options—they need context, clarity, and someone who can translate cutting-edge science into informed next steps. That is what we provide.

Note: We do not provide direct medical treatment or referrals. Final decisions remain with the treating physician and patient.

Innovative Therapies We Help You Access

Unlock access to the latest breakthroughs in medicine for patients with limited options. We connect you to leading clinics and research centers offering:

• Stem cell therapy
• CAR-T, CAR-NK and TIL immune cell therapy
• Peptide and mRNA-based cancer vaccines
• Next generation molecular pathology and diagnostic assays
• Gene therapy
• Oncolytic virotherapy
• Other novel medications not yet available in conventional treatment

These advanced treatments are at the forefront of medical innovation, providing hope where regular therapies are failing, inaccessible, or simply not enough.

Who Can Benefit?

If you or your patient is facing a serious condition with limited treatment options, you may qualify for investigational therapies through clinical trials, compassionate use, or expanded access programs.

We guide access for patients facing:

Disease	Example Conditions
Solid tumors	Colorectal, lung, breast, pancreatic, glioblastoma cancer, and more
Blood cancers	Leukemia, lymphoma, multiple myeloma
Autoimmune diseases	Diabetes, multiple sclerosis
Rare genetic disorders	Muscular dystrophies, spinal muscular atrophy, sickle cell disease
Neurological disorders	ALS, Parkinson’s disease
Metabolic disorders	Mucopolysaccharidoses, adrenoleukodystrophy

And other severe, rare, or refractory conditions not responsive to current standard treatments. Not sure if your case fits? Contact us to discuss your unique situation and explore innovative options.

Let us help you access tomorrow’s medicine—today.

Consulting Packages & Pricing

We offer flexible services depending on the patient’s needs and stage of decision-making.

Service Packages

Service	Details	Price
Initial case screening	Short assessment to determine if advanced options may exist	Free
Full research report	Tailored report with scientifically sound options and contacts	€350
Clinical coordination support	Communication with clinics and assistance in medical documentation	€250
1-on-1 consulting Session (Live, Virtual)	Scientific explanation of findings and Q&A with patient/family	$100/hour

Complete package: €600 (Research + Coordination + Consulting)

In select cases, these costs may be reimbursed or credited by destination clinics when formal collaboration agreements are in place.

Interested in Our Services?

Whether you are a patient, family member, medical travel facilitator, or healthcare provider, Biomedical Revolution is here to offer guidance based on evidence, not guesswork.

We are also open to establishing formal partnerships with treatment centers, clinical trial units, medical tourism and referring agencies who value safe, ethical, and science-guided patient navigation.

To begin, contact us at:

• 📧 omid.fotouhi@biomedrevolution.com
• 🔗 www.biomedrevolution.com